Epinephrine-induced panic attacks and hyperventilation

Journal of Psychiatric Research

Volumn 33, Issue 1, 1999, Pages 73-78

  Van Zijderveld, G A ^a   Veltman, D J ^a   Van Dyck, R ^a   Van Doornen, L J P ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CARBON DIOXIDE;

ANXIETY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; HYPERVENTILATION; LUNG VENTILATION; MALE; PANIC; PRIORITY JOURNAL; SOCIAL PHOBIA;

EID: 0032943749     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(98)00051-X     Document Type: Article

References (40)

1. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders. 3rd ed. (revised). Washington, DC: American Psychiatric Association, 1987.
2. American Psychiatric Association Committee on Nomenclature and Statistics. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
3. Appleby IL, Klein DF, Sachar EJ, Levitt M. Biochemical indices of lactate-induced panic: a preliminary report. In: Klein DF, Rabkin J, editors. Anxiety: new research and changing concepts. New York: Raven Press, 1981. p. 411-23.
4. Breggin PR. The psychophysiology of anxiety: with a review of the literature concerning adrenaline. Journal of Nervous Mental Disease 1964;139:558-68.
5. Chambless DL, Caputo GC, Bright P, Gallagher R. Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobics cognitions questionnaire. Journal of Consulting and Clinical Psychology 1984;52:1090-7.
6. Clark DM. A cognitive approach to panic. Behaviour Research and Therapy, 1986;24:461-70.
7. Coplan JD, Klein DF. Pharmacological probes in panic disorder. In: Westenberg HGM, den Boer JA, Murphy DL, editors. Advances in the neurobiology of anxiety disorders. Chichester: Wiley, 1996. p. 173-96.
8. De Ruiter C. Anxiety disorders interview schedule - revised. Dutch translation. Rijksuniversiteit Utrecht, Department of Psychiatry, 1989.
9. Dimsdale JE, Moss J. Plasma catecholamines in stress and exercise. Journal of the American Medical Association 1980a;243:340-2.
10. Dimsdale JE, Moss J. Short-term catecholamine response to psychological stress. Psychosomatic Medicine 1980b;42:493-7.
11. DiNardo PA, Barlow DH. Anxiety disorders interview schedule-revised (ADIS-R). Albany: State University of New York, 1989.
12. Ehlers A, Margraf J, Roth WT. Interaction of expectancy effects and stressors in a laboratory model of panic. In: Hellhammer D, Florin I, Weiner H, editors. Neurobiological approaches to human disease. Toronto: Huber, 1988.
13. 2 by two noninvasive methods in the critically ill newborn infant. Journal of Pediatrics 1985;106:282-6.
14. Garssen B, Buikhuisen M, van Dyck R. Hyperventilation and panic attacks. American Journal of Psychiatry 1996;153:513-8.
15. 2. Journal of Psychophysiology 1994;8:231-40.
16. Goldstein DS. Stress, catecholamines, and cardiovascular disease. New York/Oxford: Oxford University Press, 1995.
17. German JM, Liebowitz MR, Fyer AJ et al. Treatment of social phobia with atenol. Journal of Clinical Psychopharmacology 1985;5:298-301.
18. German JM, Fyer AJ, Goetz R, Askanzi J et al. Ventilatory physiology of patients with panic disorder. Archives of General Psychiatry 1988;45:31-9.
19. Guttmacher LB, Murphy DL, Insel TR. Pharmacological models of anxiety. Comprehensive Psychiatry 1983;24:312-26.
20. Hoffman B, Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Goodman- Gilman AG, Limbird LE, editors. The pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996. p. 199-248.
21. Hornsveld HK, Garssen B, Fiedeldij Dop MJC, van Spiegel PI, de Haes JCJM. Double-blind placebo-controlled study of the hyperventilation provocation test and the validity of the hyperventilation syndrome. The Lancet 1996;348:154-8.
22. Lader M. Beta-adrenoceptor antagonists in neuropsychiatry: an update. Journal of Clinical Psychiatry 1988;49:213-23.
23. Ley R. Breathing retraining in the treatment of hyperventilatory complaints and panic disorder: A reply to Garssen, De Ruiter, and Van Dyck. Clinical Psychology Review 1993;13:393-408.
24. Liebowitz MR, Fyer AJ, Gorman JM, Dillon D, Appleby IL, Levy G, Anderson S, Levitt M, Palij M, Klein DF. Lactate provocation of panic attacks: I. Clinical and behavioral findings. Archives of General Psychiatry 1984;41:764-70.
25. Liebowitz MR, Gorman JM, Fyer AJ, Levitt M, Dillon D, Levy G, Appleby IL, Anderson S, Palij M, Davies SO, Klein DF. Lactate provocation of panic attacks: II. Biochemical and physiological findings. Archives of General Psychiatry 1985;42:709-19.
26. Norman TR, Judd FJ, Burrows GD. Catecholamines and anxiety. In: Burrows GD, Roth M, Noyes R, editors. The neurobiology of anxiety. Elsevier Science Publishers B.V., 1990. p. 223-41.
27. Papillo JF, Murphy PM, Gorman, JM. Psychophysiology. In: Last CG, Hersen M, editors. Handbook of anxiety disorders. New York: Pergamon Press, p. 217-50.
28. Papp LA, Gorman JM, Liebowitz MR, Fyer AJ, Cohen B, Klein DF. Epinephrine infusions in patients with social phobia. American Journal of Psychiatry 1988;145:733-6.
29. Papp LA, Martinez JM, Klein DF et al. Respiratory physiology of panic disorder: three respiratory challenges in 98 subjects. American Journal of Psychiatry 1997;154:1557-65.
30. 2. Clinical Respiratory Physiology 1997;23:9-13.
31. Settels JJ, Wesseling KH. FIN.A.PRES: Non-invasive finger arterial pressure waveform registration. In: Orlebeke JF, Mulder G, van Doornen LJP, editors. The psychophysiology of cardiovascular control. New York: Plenum Press, p. 267-83.
32. 2 electrode design, calibration and temperature gradient problems. Acta Anaesthesiologica Scandinavica 1978;68:118-22.
33. Steurer J, Hoffmann U, Dur P, Russi E, Vetter W. Changes in arterial and transcutaneous oxygen and carbon dioxide tensions during and after voluntary hyperventilation. Respiration 1997;64(3):200-5.
34. Tyrer P, editor. Psychopharmacology of anxiety. New York: Oxford Medical Publications, 1989.
35. Uhde TW, Tancer ME. Chemical models of panic: a review and critique. In: Tyrer P, editor. Psychopharmacology of Anxiety. New York: Oxford Medical Publications, 1989.
36. Van den Hout MA. The explanation of experimental panic. In: Rachman S, Maser JD, editors. Panic: psychological perspectives. Hillsdale, N. N.J.: Lawrence Erlbaum, 1988.
37. Van Faassen I, Popp-Sijders C, Nauta JJP, van Zijderveld GA, van Doornen LJP, Tilders FJH. Platelet catecholamine contents as related to trait anxiety and aerobic fitness. American Journal of Physiology 1992;263:E245-9.
38. Van Zijderveld GA, TenVoorde BJ, Veltman DJ, van Doornen LJP, Orlebeke JF, van Dyck R, Tilders FJH. Cardiovascular, respiratory and panic reactions reactions to epinephrine in panic disorder patients. Biological Psychiatry 1997;41:249-51.
39. Veltman DJ, van Zijderveld GA, van Dyck R. Epinephrine infusions in Panic Disorder: A double blind placebo-controlled study. Journal of Affective Disorders 1996a;39:133-40.
40. Veltman DJ, van Zijderveld GA, Tilders FJH, van Dyck R. Epinephrine and fear of bodily sensations in panic disorder and social phobia. Journal of Psychopharmacology 1996b;10:259-65.